Abstract
A 72-year-old male treated with flutamide for metastatic prostate cancer developed lethargy and confusion. He was noted to be icteric and his liver enzymes were elevated. Within a week of dicontinuing the medication, the patient's mental status and liver function returned to normal. Although flutamide-induced near fatal liver dysfunction has been described, progression to encephalopathy is a rare occurrence. Based on a review of the literature, management guidelines for the use of flutamide are suggested.
Translated title of the contribution | Hepatic encephalopathy secondary to administra-tion of flutamide for prostate cancer |
---|---|
Original language | French |
Pages (from-to) | 123-125 |
Number of pages | 3 |
Journal | Journal d'urologie |
Volume | 102 |
Issue number | 3 |
State | Published - Dec 1 1996 |
Keywords
- Flutamide
- Hepatic encephalopathy
- Prostate cancer
ASJC Scopus subject areas
- Urology